239 Users Online
Kennel Cough Treatment Market Segmented By drug type that is Baytril, Doxycycline, Clavamox with route of administration that is Oral, Injectables, Intra-nasal
Kennel Cough is a highly contagious respiratory disease of dogs characterized by a severe honking cough. Kennel cough can be caused by several infectious agents such as canine adenovirus 2, parainfluenza virus, mycoplasma, canine respiratory coronavirus, and bordetella bronchiseptica.
These infectious agents affect the cells of the respiratory tract causing damage and irritation of the trachea and bronchi of the lungs. Kennel cough can be treated by cough suppressants and antibiotics such as baytril, doxycycline, and others. The global kennel cough treatment market is expected to expand during the forecast period with the increasing dog adoption and ownership and growing awareness of pets care, especially in developing countries.
Pandemic coronavirus is believed to have a negative impact on the global kennel Cough treatment market. Kennel cough treatment market manufacturing industries are being shuttered around the world causing an unusual technology and business model transformation.
There has been a disruption in the production and supply of kennel cough treatment medicines due to the global restrictions. As the impact of coronavirus continues to be felt across the world, the veterinary drug industries are trying to monitor the situation and ensure a stable supply of the drugs.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The increasing prevalence of infectious disease and rising awareness about dog care are the major drivers of the global kennel cough treatment market. Furthermore, expansion of the dog healthcare sector and rising adoption and ownership of dogs is likely to boost the growth of the global kennel cough treatment market.
However, there are some factors which can restrain the growth of the kennel cough treatment market such as lack of awareness of dog care in some countries and the adverse reactions (salivation, vomition, and depression) of some drugs.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version| Based on the drug type |
|
| Based on the route of administration |
|
| Based on the distribution channel |
|
Based on the product type, the baytril segment is expected to hold a major share in the global kennel cough treatment market as it is the drug of choice. Based on the route of administration, the oral segment is expected to dominate the global kennel cough treatment market.
Based on the distribution channel, veterinary hospitals are expected to be the most profitable segment in the global kennel cough treatment market due to the higher number of visits in veterinary hospitals.
Sales Team
Client Partner
North America is expected to dominate the global kennel cough treatment market, due to the increasing rate of adoption and ownership of the dog. Also, the rising adoption of kennel treatment medicines and investing a considerable amount on dogs, among all pets are likely to drive the kennel cough treatment market in the region.
North America is expected to be followed by Europe due to the growing demand for animal care in the region. Asia-Pacific is expected to have a significant growth in the global kennel cough treatment market over the forecast period due to the rising incidence of various zoonotic diseases, rising concern about dogs, and increasing awareness about maintaining dog health is fueling the kennel cough treatment market in the region.
In countries like India and China, the average income population spends more on their pets, this is also likely to drive the market growth in the region.
There are some of the market leaders in the global kennel cough treatment market identified across the value chain: Pfizer Inc., Zoetis Inc., Bayer AG, and others.
